Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics.
External link for Menten AI
San Francisco, CA 94111, US
100 College St
Toronto, Ontario, CA
Don’t miss the chance to talk to Menten AI’s cofounders Hans Melo and Vikram K. Mulligan at the European Peptide Symposium in Florence, Italy this week. #EPS2024 #AIDrugDiscovery #CADD
Excited to be attending the European Peptide Symposium in Florence, Italy - what a magical place to hold a conference. If you're around, don't be shy. Come talk to us! Menten AI Vikram K. Mulligan #eps2024 #aidrugdiscovery
How can generative AI advance drug discovery for cyclic peptides? Our CEO, Hans Melo, will be sharing the latest developments at Menten AI in Boulder on adding drug-like properties including plasma stability and membrane-permeability. You do not want to miss it! #genai #CADD #peptidedrugs #aifordrugdiscovery
JUST ANNOUNCED! Our day 2 Peptide Showcase session is FULL! We are so excited to hear from JP Robles from VIAN Therapeutics, Michael Lipp, Ph.D. from Decoy Therapeutics Inc., Rick Ewing from Rapafusyn Pharmaceuticals, Hans Melo from Menten AI, and Fa Liu from Full-Life Technologies! Register today at: https://lnkd.in/gtcdZW6a Thank you to our SAB members who helped make this session possible! Wendy Hartsock from Aralez Bio, Christopher McGee, Ph.D. from Bachem. #peptide #peptides #peptidechemistry
What's driving all the recent excitement and investment in peptide macrocycles? Have a look at this article by C&EN featuring Menten AI and co-founder Vikram K. Mulligan on the disruptive potential of peptide macrocycles. #aidrugdiscovery #peptides #AI #biotech #genAI
This week in the C&EN Magazine: Industry braces for Biosecure Act impact + Macrocyclic peptides: Aiming for the perfect fit + Wildfire smoke linked to early deaths. Read more: https://lnkd.in/eDFHhSvQ
Did you know that 90% of disease-causing proteins are undruggable with conventional therapeutics like small molecules and biologics? 🤔 This is in great part due to their flat or featureless protein surfaces which are not amenable to binding by small molecules, or being located inside the cell-membrane making them inaccessible to biologics. Next-generation cyclic peptides have received much attention recently for their ability cross-membranes and bind to featureless sites making them ideal for tackling these difficult targets.✅ What to find out how to exploit this promising drug modality? Talk to us. 👋 #aidrugdiscovery #genai #biotech #drugdiscovery #peptides #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation #machinelearning #ml
Menten AI reposted this
We’re excited to announce our collaboration with Bristol Myers Squibb applying Menten AI’s generative AI platform to peptide optimization. By leveraging Menten AI’s generative AI platform and the team’s expertise, we were able to explore a more expansive chemical space and identify new amino acid modifications to improve the desired properties of peptide macrocycles. It’s been a pleasure working with the world-class scientists at Bristol Myers Squibb. Thank you for the incredible collaboration! This is a key milestone for Menten AI, as it demonstrates the maturity of our platform and of generative AI more broadly, to accelerate the discovery and optimization of next-generation peptide macrocycles. Learn more about this collaboration: https://lnkd.in/dcW-8bdq #aidrugdiscovery #genai #biotech #drugdiscovery #peptides #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation #machinelearning #ml
We’re excited to announce our collaboration with Bristol Myers Squibb applying Menten AI’s generative AI platform to peptide optimization. By leveraging Menten AI’s generative AI platform and the team’s expertise, we were able to explore a more expansive chemical space and identify new amino acid modifications to improve the desired properties of peptide macrocycles. It’s been a pleasure working with the world-class scientists at Bristol Myers Squibb. Thank you for the incredible collaboration! This is a key milestone for Menten AI, as it demonstrates the maturity of our platform and of generative AI more broadly, to accelerate the discovery and optimization of next-generation peptide macrocycles. Learn more about this collaboration: https://lnkd.in/dcW-8bdq #aidrugdiscovery #genai #biotech #drugdiscovery #peptides #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation #machinelearning #ml
One of the major challenges of applying #AI in drug discovery is not the lack of large data sets, it's the lack of #ML methods that can leverage small data sets - which are the rule, not the exception, in drug discovery 💊. At Menten AI we’ve been advancing #ML models that leverage few data points to extract useful insight and guide multi-parameter drug design and optimization ✅. #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation #machinelearning #ml
Menten AI reposted this
The landscape of peptide therapeutics has evolved significantly over time 📈. Today, we’re leveraging the power of #generativeAI to accelerate the 4th generation of peptide drugs, creating peptides with precision and tailored drug-like properties 💊. Reach out to learn how Menten AI is forging ahead! 👋 https://www.menten.ai #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation
The landscape of peptide therapeutics has evolved significantly over time 📈. Today, we’re leveraging the power of #generativeAI to accelerate the 4th generation of peptide drugs, creating peptides with precision and tailored drug-like properties 💊. Reach out to learn how Menten AI is forging ahead! 👋 https://www.menten.ai #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation
Unlocking the therapeutic power of peptides is a fine art, blending chemical diversity, membrane permeability, stability, and potency just right 🎨. At Menten AI, we leverage machine learning to achieve multi-parameter design - creating peptides with the right drug properties ✅. #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology